Dual antitubercular drug loaded liposomes for macrophage targeting: development, characterisation, ex vivo and in vivo assessment

References

• Bangham, A.D., Standish, M.M., and Watkins, J.C., 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of molecular biology, 13 (1), 238–IN27.
   PubMed Web of Science ®Google Scholar
• Bhardwaj, A., et al., 2013. Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis. Artificial cells, nanomedicine, and biotechnology, 41 (1), 52–59.
   PubMed Web of Science ®Google Scholar
• Brandhonneur, N., et al., 2009. Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 36 (4-5), 474–485.
   PubMed Web of Science ®Google Scholar
• Caliskan, Y., et al., 2019. A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co-loaded liposomal formulation. International journal of pharmaceutics, 557, 97–104.
   PubMed Web of Science ®Google Scholar
• Chandran, A., et al., 2015. Mycobacterium tuberculosis infection induces HDAC1-mediated suppression of IL-12B gene expression in macrophages. Frontiers in cellular and infection microbiology, 5, 90.
   PubMed Web of Science ®Google Scholar
• Chieppa, M., et al., 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. Journal of immunology (Baltimore, Md. : 1950), 171 (9), 4552–4560.
   PubMed Web of Science ®Google Scholar
• Chuan, J., et al., 2013. Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles. Journal of nanoparticle research, 15 (5), 1634.
   Web of Science ®Google Scholar
• Claassen, E., 1992. Post-formation fluorescent labelling of liposomal membranes: in vivo detection, localisation and kinetics. Journal of immunological methods, 147 (2), 231–240.
   PubMed Web of Science ®Google Scholar
• Cooper, A.M., 2009. Cell-mediated immune responses in tuberculosis. Annual review of immunology, 27, 393–422.
   PubMed Web of Science ®Google Scholar
• Costa, A., Sarmento, B., and Seabra, V., 2018. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 114, 103–113.
   PubMed Web of Science ®Google Scholar
• Dikpati, A., et al., 2020. Residual Solvents in Nanomedicine and Lipid-Based Drug Delivery Systems: a Case Study to Better Understand Processes. Pharmaceutical Research, 37 (8), 1–11. doi:10.1007/s11095-020-02877-x
   Web of Science ®Google Scholar
• Donnellan, S. and Giardiello, M., 2019. Nanomedicines towards targeting intracellular Mtb for the treatment of tuberculosis. Journal of interdisciplinary nanomedicine, 4 (3), 76–85.
   Google Scholar
• Dutt, M. and Khuller, G.K., 2001. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles. The journal of antimicrobial chemotherapy, 47 (6), 829–835.
   PubMed Web of Science ®Google Scholar
• Garg, M., et al., 2006. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics . The journal of pharmacy and pharmacology, 58 (5), 605–616.
   PubMed Web of Science ®Google Scholar
• Hamed, A., et al., 2019. Enhanced antitubercular activity, alveolar deposition and macrophages uptake of mannosylated stable nanoliposomes. Journal of drug delivery science and technology, 51, 513–523.
   Web of Science ®Google Scholar
• Irache, J.M., et al., 2008. Mannose-targeted systems for the delivery of therapeutics. Expert opinion on drug delivery, 5 (6), 703–724.
   PubMed Web of Science ®Google Scholar
• Jahagirdar, P.S., et al., 2020. Intramacrophage delivery of dual drug loaded nanoparticles for effective clearance of Mycobacterium tuberculosis. Journal of pharmaceutical sciences, 109 (7), 2262–2270.
   PubMed Web of Science ®Google Scholar
• Jain, C.P. and Vyas, S.P., 1995. Preparation and characterization of niosomes containing rifampicin for lung targeting. Journal of microencapsulation, 12 (4), 401–407.
   PubMed Web of Science ®Google Scholar
• Kawakami, S., et al., 2000. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochimica et biophysica acta (BBA) - general subjects, 1524 (2-3), 258–265.
   PubMed Web of Science ®Google Scholar
• Labana, S., et al., 2002. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. International journal of antimicrobial agents, 20 (4), 301–304.
   PubMed Web of Science ®Google Scholar
• Liu, T., et al., 2018. Preparation of glycyrrhetinic acid liposomes using lyophilization monophase solution method: preformulation, optimization, and in vitro evaluation. Nanoscale research letters, 13 (1), 324
   PubMed Web of Science ®Google Scholar
• Lombry, C., et al., 2002. Confocal imaging of rat lungs following intratracheal delivery of dry powders or solutions of fluorescent probes. Journal of controlled release : official journal of the controlled release society, 83 (3), 331–341.
   PubMed Web of Science ®Google Scholar
• Luo, Q., et al., 2017. ATB0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes. Biomaterials science, 5 (2), 295–304.
   PubMed Web of Science ®Google Scholar
• MacLean, E., et al., 2019. A systematic review of biomarkers to detect active tuberculosis. Nature microbiology, 4 (5), 748–758.
   PubMed Web of Science ®Google Scholar
• Mehta, M., et al., 2019. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases. Chemico-biological interactions, 304, 10–19.
   PubMed Web of Science ®Google Scholar
• Ngamwongsatit, P., et al., 2008. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. Journal of microbiological methods, 73 (3), 211–215.
   PubMed Web of Science ®Google Scholar
• Nishikawa, M., et al., 1992. Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. International journal of pharmaceutics, 85 (1-3), 75–85.
   Web of Science ®Google Scholar
• Nkanga, C.I., et al., 2020. Co-loading of isoniazid-grafted phthalocyanine-in-cyclodextrin and rifampicin in crude soybean lecithin liposomes: formulation, spectroscopic and biological characterization. Journal of biomedical nanotechnology, 16 (1), 14–28.
   PubMed Web of Science ®Google Scholar
• Opanasopit, P., et al., 2001. Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages. Biochimica et biophysica acta (BBA) - biomembranes, 1511 (1), 134–145.
   PubMed Web of Science ®Google Scholar
• Pandey, R., et al., 2003. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. The journal of antimicrobial chemotherapy, 52 (6), 981–986.
   PubMed Web of Science ®Google Scholar
• Pandey, R., Sharma, S., and Khuller, G.K., 2005. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinburgh, Scotland)), 85 (5-6), 415–420.
   PubMed Web of Science ®Google Scholar
• Pham, D.D., et al., 2015. Pulmonary delivery of pyrazinamide-loaded large porous particles. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.v, 94, 241–250.
   PubMed Web of Science ®Google Scholar
• Prior, S., et al., 2002. In vitro phagocytosis and monocyte-macrophage activation with poly (lactide) and poly (lactide-co-glycolide) microspheres. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 15 (2), 197–207.
   PubMed Web of Science ®Google Scholar
• Rajaram, M.V., et al., 2017. M. tuberculosis-initiated human mannose receptor signaling regulates macrophage recognition and vesicle trafficking by FcRγ-Chain, Grb2, and SHP-1. Cell reports, 21 (1), 126–140.
   PubMed Web of Science ®Google Scholar
• Rawal, T., et al., 2017. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis. Colloids and surfaces. B, biointerfaces, 154, 321–330.
   PubMed Web of Science ®Google Scholar
• Rohde, K., et al., 2007. Mycobacterium tuberculosis and the environment within the phagosome. Immunological reviews, 219 (1), 37–54.
   PubMed Web of Science ®Google Scholar
• Sharma, A., et al., 2020. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis. Journal of controlled release, 324, 17–33.,
   PubMed Web of Science ®Google Scholar
• Sharma, R., et al., 2007. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra. The journal of antimicrobial chemotherapy, 59 (3), 499–506.
   PubMed Web of Science ®Google Scholar
• Shilpi, S., Vimal, V.D., and Soni, V., 2015. Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung. Progress in biomaterials, 4 (1), 55–63.
   PubMed Web of Science ®Google Scholar
• Singh, M., et al., 2019. Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics. Nanomedicine (London, England)), 14 (4), 465–491.
   PubMed Web of Science ®Google Scholar
• Tian, B., et al., 2017. Mannose-coated gadolinium liposomes for improved magnetic resonance imaging in acute pancreatitis. International journal of nanomedicine, 12, 1127–1141.
   PubMed Web of Science ®Google Scholar
• Vieira, A.C., et al., 2017. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment. Nanomedicine, 12 (24), 2721–2736.
   PubMed Web of Science ®Google Scholar
• Vieira, A.C., et al., 2018. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages. Artificial cells, nanomedicine, and biotechnology, 46 (suppl 1), 653–663.
   PubMed Web of Science ®Google Scholar
• Voskuil, M.I., et al., 2011. The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species. Frontiers in microbiology, 2, 105.
   PubMed Web of Science ®Google Scholar
• Vyas, S.P., et al., 2004. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. International journal of pharmaceutics, 269 (1), 37–49.
   PubMed Web of Science ®Google Scholar
• Wijagkanalan, W., et al., 2008. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release, 125 (2), 121–130.
   PubMed Web of Science ®Google Scholar
• Zenaro, E., Donini, M., and Dusi, S., 2009. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGN. Journal of leukocyte biology, 86 (6), 1393–1401.
   PubMed Web of Science ®Google Scholar